rTMS: The Future of Treatment-Resistant Depression

Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive, FDA-approved therapy that uses focused magnetic pulses to stimulate specific regions of the brain. It is especially effective for patients who have not responded adequately to two or more antidepressants. At Manas, our neuromodulation suite is equipped with the latest figure-of-eight coil technology. A typical course runs for 4 to 6 weeks with sessions of about 30 minutes. Research shows remission rates of 30-50% in treatment-resistant cases — a number that continues to improve as protocols are refined.